ClinicalTrials.gg
Sign In
Drug

Bevacizumab clinical trials

Also written Avastin, ONS-5010 and NSC 704865.

Includes 1 study of BEVZ92.

studies test it
1,568
open now
199
in phase 3
266
first study started
1998
Related medicines add 2 studies

Counted the way a researcher would: Bevacizumab with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Bevacizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Bevacizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Feb 2004 · AVASTIN · BLA 125085 (FDA, Drugs@FDA)
European Union
12 Jan 2005 · Avastin · EMEA/H/C/000582 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bevacizumab
1,116
anti-VEGF monoclonal antibody
114
anti-VEGF humanized monoclonal antibody
85
rhuMAb VEGF
82
rhuMAb-VEGF
65

Brand

Byvasda
1

Development codes

ONS-5010
5
NSC 704865
5
RO4876646
4
BCD-021
2
SIBP-04
2
HLX04-O
1
PF-06439535
1

Other names

Avastin
639

In one entry with another drug

Given together, or one or the other

FOLFOXIRI + Bevacizumab
4
Atezolizumab & Bevacizumab
3
bevacizumab, erlotinib
3
FOLFIRI + bevacizumab
2
Bevacizumab and Erlotinib
2
S-1, Irinotecan, Bevacizumab
2
triamcinolone and bevacizumab
2
XELOX + Bevacizumab
2

Studies by the year they started

1,555 studies that test it; most in 2006 (163); 2 more planned to start later

Studies that test Bevacizumab, by start year
YearStudies
19981
19991
20004
200114
200214
200319
200429
200589
2006163
2007140
2008122
2009117
201096
201161
201255
201361
201440
201526
201647
201741
201839
201942
202049
202147
202240
202347
202446
202552
202653

By phase

A phase 1/2 study counts in both.

Early Phase 1
19
Phase 1
281
Phase 2
1,008
Phase 3
266
Phase 4
61
No phase
72

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Colorectal Neoplasms
201
Carcinoma, Non-Small-Cell Lung
120
Breast Neoplasms
111
Glioblastoma
74
Ovarian Neoplasms
72
Carcinoma, Hepatocellular
60
Carcinoma, Renal Cell
42
Pancreatic Neoplasms
30
Rectal Neoplasms
29
Macular Degeneration
29
Colonic Neoplasms
22
Melanoma
22

Who runs them

Industry 282 · Other 1,286

National Cancer Institute (NCI) (120) · Hoffmann-La Roche (87) · M.D. Anderson Cancer Center (60) · Genentech, Inc. (33) · Memorial Sloan Kettering Cancer Center (22) · Sun Yat-sen University (21) · Dana-Farber Cancer Institute (19) · Duke University (19)

Often tested with

Tested in the same studies.

Paclitaxel (121) · Carboplatin (110) · Capecitabine (101) · Oxaliplatin (84) · Irinotecan (82) · Atezolizumab (75) · Gemcitabine (70) · Erlotinib (63)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 24 phase 3 studies under way

Bevacizumab is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 68, 12 in phase 3

Studies that test Bevacizumab, phase 3 first.

Studies

Open first, then newest update. How each study uses Bevacizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 1,568

See all 1,568 studies that test Bevacizumab →

Given beside what is tested · 788 — Bevacizumab is usual care or a partner of the new treatment

Showing 20 of 788.

As the comparator · 105 — what is tested is compared with Bevacizumab

Showing 20 of 105.

Codes

What other systems call Bevacizumab · ClinicalTrials.gg INT006505

  • MeSH (NLM) D000068258BevacizumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2S9ZZM9Q9VBEVACIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 253337Confirmed FDA, Wikidata
  • Wikidata Q413299bevacizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2039BevacizumabOne source FDA
  • DrugBank DB00112One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.